JIR
AGN

James Investment Research’s Allergan plc AGN Stock Holding History

James Investment Research’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-500
Closed -$149K – 520
2015
Q1 		$149K Hold
500
– – ﹤0.01% 330
2014
Q4 		$129K Hold
500
– – ﹤0.01% 333
2014
Q3 		$121K Sell
500
-50
-9% -$11.2K ﹤0.01% 344
2014
Q2 		$123K Sell
550
-92
-14% -$19K ﹤0.01% 335
2014
Q1 		$132K Sell
642
-414
-39% -$82K ﹤0.01% 342
2013
Q4 		$177K Buy
+1,056
New +$165K 0.01% 318
2013
Q3 		– Sell
-295
Closed -$37K – 543
2013
Q2 		$37K Buy
+295
New +$33.4K ﹤0.01% 379

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

James Investment Research's AGN Position: Q2 2015 in Review

James Investment Research sold out of Allergan plc (AGN) in Q2 2015, closing a stake of 500 shares — an estimated $149K sold.

James Investment Research first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $177K in Q4 2013. 1,035 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

  • James Investment Research reported no remaining Allergan plc position as of Q2 2015 after selling out during the quarter.
  • James Investment Research sold 500 Allergan plc shares in Q2 2015, an estimated $149K.
  • James Investment Research first reported a position in Allergan plc in Q2 2013 and held it in 7 quarters.
  • James Investment Research's Allergan plc position peaked at $177K in Q4 2013.
  • 1,035 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on James Investment Research's 13F filing for Q2 2015, filed 17 Jul 2015.